Creating a new workplace roadmap: returning to the office after the pandemic

June 23, 2021 11:00 AM - 11:45 AM

Webinar, click "live-stream" button to view

Add to Calendar 6/23/2021 11:00:00 AM 6/23/2021 11:45:00 AM Creating a new workplace roadmap: returning to the office after the pandemic Throughout the pandemic, much of the life sciences continued to work in-person - schedules, activities, and safety protocols evolved and those working onsite and at home adapted.

Now, as COVID-19 cases decrease and the country moves closer to a full reopening, companies are navigating the "next normal" in the life sciences.

In this virtual Forum, panelists will share insights on:
  • Managing the short term, near term, and long term implications of return to office
  • Balancing organizational prioritizes with team wellbeing
  • How lessons learned during the pandemic may lead to a more fluid working environment in the future
Webinar, click "live-stream" button to view
Throughout the pandemic, much of the life sciences continued to work in-person - schedules, activities, and safety protocols evolved and those working onsite and at home adapted.

Now, as COVID-19 cases decrease and the country moves closer to a full reopening, companies are navigating the "next normal" in the life sciences.

In this virtual Forum, panelists will share insights on:
  • Managing the short term, near term, and long term implications of return to office
  • Balancing organizational prioritizes with team wellbeing
  • How lessons learned during the pandemic may lead to a more fluid working environment in the future
Executive Director, Discovery Research Coordination, Boehringer Ingelheim Pharmaceuticals, Inc.
Martha Brown is Executive Director of Discovery Research Coordination at Boehringer Ingelheim Pharmaceuticals, Inc. In this role she leads strategic and operational functions in Discovery Research coordinating local initiatives and ensuring harmonization with Boehringer Ingelheim’s global Discovery Research efforts. During her two decades at Boehringer Ingelheim, Martha has worked across drug discovery and development from exploratory research to Phase 3 clinical trials. Prior to her current role, Martha led Target Enabling Science and Technology, encompassing High Throughput Biology, Structural Biology, Compound Profiling and Sample Management functions for all small molecule projects originating at the US Discovery Research site. Her earlier work includes formulator for Aptivus®, for the treatment of HIV. Prior to her time at Boehringer Ingelheim, Martha was a National Research Science Award funded post-doctoral researcher at the University of Wisconsin-Madison. Martha earned a Ph.D. from The Johns Hopkins University.